{"id":"https://openalex.org/W2425571817","doi":"https://doi.org/10.1158/1557-3125.myc15-b37","title":"Abstract B37: Targeting Myc-reprogrammed glutamine metabolism for treatment of neuroblastoma","display_name":"Abstract B37: Targeting Myc-reprogrammed glutamine metabolism for treatment of neuroblastoma","publication_year":2015,"publication_date":"2015-10-01","ids":{"openalex":"https://openalex.org/W2425571817","doi":"https://doi.org/10.1158/1557-3125.myc15-b37","mag":"2425571817"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3125.myc15-b37","doi":"https://doi.org/10.1158/1557-3125.myc15-b37","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3125.myc15-b37","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058425834","display_name":"Rachelle R. Olsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachelle R. Olsen","raw_affiliation_strings":["St. Jude Children's Research Hospital, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Jude Children's Research Hospital, Memphis, TN","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063170526","display_name":"Michelle N. Mary-Sinclair","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle N. Mary-Sinclair","raw_affiliation_strings":["St. Jude Children's Research Hospital, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Jude Children's Research Hospital, Memphis, TN","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086019888","display_name":"Zhirong Yin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhirong Yin","raw_affiliation_strings":["St. Jude Children's Research Hospital, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Jude Children's Research Hospital, Memphis, TN","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059730517","display_name":"Kevin W. Freeman","orcid":"https://orcid.org/0000-0002-8952-5422","observed_orcids":["https://orcid.org/0000-0002-8952-5422"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin W. Freeman","raw_affiliation_strings":["St. Jude Children's Research Hospital, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Jude Children's Research Hospital, Memphis, TN","institution_ids":["https://openalex.org/I1313298211"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1313298211"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":"10_Supplement","first_page":"B37","last_page":"B37"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.013500000350177288,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.9900000095367432},{"id":"https://openalex.org/keywords/mycn-amplification","display_name":"MYCN amplification","score":0.9430000185966492},{"id":"https://openalex.org/keywords/glutamine-metabolism","display_name":"glutamine metabolism","score":0.7839999794960022},{"id":"https://openalex.org/keywords/glutamine-antagonist","display_name":"glutamine antagonist","score":0.6949999928474426},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.5289999842643738},{"id":"https://openalex.org/keywords/glutamine-addiction","display_name":"glutamine addiction","score":0.5929999947547913},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6029999852180481},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.972000002861023},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.6240000128746033},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.48899999260902405},{"id":"https://openalex.org/keywords/metabolic-reprogramming","display_name":"metabolic reprogramming","score":0.4819999933242798},{"id":"https://openalex.org/keywords/cancer-therapy-targets","display_name":"cancer therapy targets","score":0.3970000147819519},{"id":"https://openalex.org/keywords/imr-32","display_name":"IMR-32","score":0.6639999747276306}],"concepts":[{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.8931494355201721},{"id":"https://openalex.org/C2779349466","wikidata":"https://www.wikidata.org/wiki/Q181619","display_name":"Glutamine","level":3,"score":0.8159224987030029},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6615629196166992},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5867984890937805},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4874277412891388},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.42616838216781616},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3535090684890747},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3243643641471863},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14290571212768555},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08345687389373779},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.06960585713386536}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3125.myc15-b37","doi":"https://doi.org/10.1158/1557-3125.myc15-b37","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3125.myc15-b37","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/6","score":0.4099999964237213,"display_name":"Clean water and sanitation"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2887372782","https://openalex.org/W2054856819","https://openalex.org/W2739809358","https://openalex.org/W7097679022","https://openalex.org/W2562178741","https://openalex.org/W2074220474","https://openalex.org/W2741421145","https://openalex.org/W2617531596","https://openalex.org/W2025495039","https://openalex.org/W2793635377"],"abstract_inverted_index":{"Abstract":[0],"Oncogenic":[1],"Myc":[2,405,421],"is":[3,19,64,166],"known":[4],"to":[5,107,136,177,183,257,266,270,311,351,429,538],"alter":[6],"cellular":[7],"metabolism":[8,53,114,490,521],"resulting":[9],"in":[10,33,36,54,78,96,115,159,274,316,338,397,419,432,449,454,474],"glutamine":[11,52,59,113,258,352,489,520],"addiction,":[12],"and":[13,103,133,169,213,289,319,384,480],"the":[14,48,58,79,109,119,188,201,263,304,356,366,398,463,475,493,530],"MYCN-amplified":[15,168,345,379,476],"subclass":[16],"of":[17,27,50,111,122,173,190,245,280,295,301,330,358,390,488,524,529],"neuroblastoma":[18,125,146,251,400,503],"associated":[20,88],"with":[21,38,89,150,209,216,229,238,365,403,451,462],"extremely":[22],"poor":[23],"prognosis.":[24],"Successful":[25],"identification":[26],"therapeutic":[28],"agents":[29],"that":[30,72,344,386,410,431,458,485],"are":[31],"effective":[32],"neuroblastoma,":[34,55],"particularly":[35,349],"tumors":[37,252,261,291,324,346],"MYCN":[39],"amplification,":[40],"could":[41],"significantly":[42,180,241,327,376],"increase":[43],"patient":[44],"survival.":[45],"To":[46,354],"explore":[47],"effect":[49,110,152,189,396],"inhibiting":[51],"we":[56,186,199,362,426,446],"used":[57,200,427],"antagonist":[60],"DON":[61,63,86,98,120,142,191,230,240,267,287,308,411,448,459],"(6-diazo-5-oxo-norleucine).":[62],"an":[65],"irreversible":[66],"competitive":[67],"inhibitor":[68,368,466],"which":[69,92,165,334],"alkylates":[70],"enzymes":[71],"utilize":[73],"glutamine.":[74],"Although":[75],"first":[76],"studied":[77],"1950s":[80],"as":[81],"a":[82,100,104,162,271,299,312],"possible":[83],"cancer":[84],"chemotherapeutic,":[85],"was":[87,175],"severe":[90],"nausea":[91],"limited":[93],"its":[94],"use":[95],"patients.":[97],"remains":[99],"potent":[101],"inhibitor,":[102],"useful":[105],"tool":[106],"study":[108],"modulating":[112],"vivo.":[116],"We":[117,456],"tested":[118,149,187,447],"sensitivity":[121],"six":[123],"human":[124],"cell":[126,147,163,202,248,360,380,401,413,423,472,477,497],"lines":[127,148,203,381,402,478],"(Kelly,":[128,382],"IMR-32,":[129],"SK-N-BE2,":[130],"SK-N-AS,":[131],"SK-N-FI,":[132],"SH-SY5Y)":[134],"compared":[135],"immortalized":[137],"BJ":[138,154],"fibroblast":[139],"control":[140],"cells.":[141,155],"effectively":[143],"inhibited":[144,242],"all":[145,246],"minimal":[151,395],"on":[153,193,471,534],"Furthermore,":[156],"MycN":[157,211,218],"overexpression":[158],"SK-N-AS":[160,204],"cells,":[161],"line":[164],"not":[167,336,443],"expresses":[170],"low":[171,404],"levels":[172,294,329,389],"cMyc,":[174],"sufficient":[176],"make":[178],"cells":[179,364,385,434],"more":[181,313],"sensitive":[182,256,265,350],"DON.":[184],"Next,":[185,425],"treatment":[192,309,371,460,523],"subcutaneous":[194],"xenografts.":[195],"For":[196],"these":[197],"experiments":[198],"(not":[205],"MYCN-amplified),":[206],"SK-N-BE2":[207],"(MYCN-amplified":[208,215],"moderate":[210],"levels),":[212],"IMR-32":[214,260,290],"high":[217,388,420],"levels).":[219],"Mice":[220],"were":[221,262,335],"treated":[222,363],"twice":[223],"per":[224],"week":[225],"by":[226,416,438],"intraperitoneal":[227],"injection":[228],"(50":[231],"or":[232,234,374],"100mg/kg)":[233],"water":[235],"control.":[236],"Treatment":[237],"50mg/kg":[239],"tumor":[243,275,496],"growth":[244],"three":[247],"lines,":[249],"suggesting":[250],"may":[253,347,499],"be":[254,348,500],"broadly":[255],"inhibitors.":[259],"most":[264],"treatment,":[268,288],"leading":[269],"6-fold":[272],"reduction":[273],"size":[276],"after":[277],"2.5":[278],"weeks":[279],"treatment.":[281,504],"Tumor":[282],"BrdU":[283,317],"incorporation":[284],"decreased":[285],"following":[286],"showed":[292,326],"increased":[293,328],"cleaved":[296,331],"caspase":[297,332],"3,":[298,333],"marker":[300],"apoptosis.":[302],"At":[303],"higher":[305],"100mg/kg":[306],"dose,":[307],"led":[310],"substantial":[314],"decrease":[315],"incorporation,":[318],"at":[320],"this":[321],"dose":[322],"BE2":[323],"also":[325],"detected":[337],"AS":[339],"tumors.":[340],"These":[341,407],"results":[342,408,483],"suggest":[343,484],"inhibition.":[353],"examine":[355],"mechanism":[357],"DON-induced":[359,435],"death,":[361],"pan-caspase":[367],"QVD.":[369],"QVD":[370],"for":[372,495,502,522],"48":[373],"72hr":[375],"rescued":[377],"both":[378],"IMR-32)":[383],"express":[387],"cMyc":[391],"(SY5Y),":[392],"while":[393,491],"having":[394],"remaining":[399],"levels.":[406],"confirm":[409],"induces":[412],"death":[414,473],"partially":[415],"activating":[417],"apoptosis":[418,436,498],"expressing":[422],"lines.":[424],"shRNA":[428],"show":[430],"Kelly":[433,479],"occurs":[437],"signaling":[439],"through":[440],"Bax,":[441],"but":[442],"Bak.":[444],"Lastly,":[445],"combination":[450],"pro-apoptotic":[452],"compounds":[453],"vitro.":[455],"found":[457],"combined":[461,486],"Bcl-2":[464],"family":[465],"ABT-263":[467],"had":[468],"synergistic":[469],"effects":[470],"BE2.":[481],"Our":[482],"targeting":[487],"reducing":[492],"threshold":[494],"beneficial":[501],"Citation":[505],"Format:":[506],"Rachelle":[507],"R.":[508],"Olsen,":[509],"Michelle":[510],"N.":[511],"Mary-Sinclair,":[512],"Zhirong":[513],"Yin,":[514],"Kevin":[515],"W.":[516],"Freeman.":[517],"Targeting":[518],"Myc-reprogrammed":[519],"neuroblastoma.":[525],"[abstract].":[526],"In:":[527],"Proceedings":[528],"AACR":[531],"Special":[532],"Conference":[533],"Myc:":[535],"From":[536],"Biology":[537],"Therapy;":[539],"Jan":[540],"7-10,":[541],"2015;":[542],"La":[543],"Jolla,":[544],"CA.":[545],"Philadelphia":[546],"(PA):":[547],"AACR;":[548],"Mol":[549],"Cancer":[550],"Res":[551],"2015;13(10":[552],"Suppl):Abstract":[553],"nr":[554],"B37.":[555]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2016-06-24T00:00:00"}